News & Analysis on Clinical Trial Services & Contract Research And Development
Manufacturers of single-use process components and systems within the biopharma industry in the US have launched a new alliance at Interphex to educate, standardise, and develop guidelines that safeguard the quality of drugs produced using their...
Scientists in the US have found out how the enzyme helps initiate the process that leads to colorectal cancer. Their discovery of a new molecular mechanism by which an enzyme promotes cancer spread may provide a new target at which to aim...
A new report out today has revealed that the uptake of assays for in-vitro diagnostics is being hindered due to a lack of knowledge of this technology, in which its high sensitivity, specificity and fast turn-around times has proved a revelation...
US filtration giant Millipore is pumping more resources into its personnel and facilities in Asia, as outsourcing trends and new laboratory investments in emerging markets such as China and India are upping demand for its bioscience products and...
Multisorb used the recent Interphex trade show to introduce its new range of consulting services to accompany its well-known range of sorbent products and save customers both time and money in drug packaging.
A leading scientist believes that cosmetic considerations and a lack of patent opportunities is stopping the pharmaceutical industry from investing in the development of a new therapy proven to be effective in the treatment of MRSA.
Nastech Pharmaceuticals presents data demonstrating the effectiveness of its small interfering RNA (siRNA) therapeutics to target and inhibit influenza viral production, which is certain to have useful applications against current and future influenza...
The damages caused by a patent dispute can sometimes wipe out the assets side of a company's balance sheet - a potential death sentence for small or medium companies - many of which aren't doing enough to protect themselves, according to a recent...
Italian packaging and processing machinery company IMA Group has posted a net profit of €13m for 2005, down 24 per cent from 2004, since a rise in revenues was offset by one-off charges, operating costs and a reduction in prices as the company tries...
Scientists have made a breakthrough in their research that may change the way inflammatory conditions are treated by focusing on certain nerve cell receptors in the brain that control inflammation in the body.